-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
[Pharmaceutical Network Industry News] Mergers and acquisitions, as an important tool for enterprises to improve the efficiency of resource allocation and enhance industrial coordination, have maintained a high degree of activity in the capital market
.
According to statistics, judging from the date of the first announcement and excluding transaction failure cases, as of August 23 this year, a total of 1,531 company mergers and acquisitions have occurred in the A-share market, an increase of 23.
66% from 1,238 in the same period last year
.
Mergers and acquisitions have become an important part of the strategic layout of pharmaceutical equipment companies! (Source: Pharmaceutical Network) It is worth noting that, from the perspective of the industry, among the 1,531 company mergers and acquisitions that occurred during the year, the number of mergers and acquisitions in the five industries of pharmaceutical biology, chemical industry, machinery and equipment, electronics and computers ranked the highest, respectively.
There were 174, 150, 135, 105 and 92 cases, accounting for 42.
8% of the total
.
From the above point of view, mergers and acquisitions have obviously become an important way for machinery and equipment companies to enter high-growth and key strategic markets
.
In this regard, the industry expects that the pharmaceutical equipment industry, which is an important member of the machinery and equipment industry, will also accelerate through mergers and acquisitions to expand more market increments for itself
.
In fact, judging from the announcements disclosed by pharmaceutical machine companies and the responses of the companies on the interactive platform, in order to improve future competitiveness, many companies have accelerated their M&A arrangements
.
For example, Truking Technology disclosed the restructuring plan on the evening of July 10, 2022, and the company plans to take the remaining 49% equity of Truking Feiyun into the bag by issuing shares
.
It is understood that as early as 2017, Truking Technology acquired a 51% stake in the newly established Truking Feiyun through capital increase
.
After the completion of this transaction, it means that Truking Feiyun will become a wholly-owned subsidiary of Truking Technology
.
According to the data, Truking Feiyun owns some assets and core technologies, core teams and sales resources of Zhejiang Feiyun, and has a high level of technology and an advantageous position in the field of domestic automatic capsule filling machines
.
Regarding this acquisition, Chutian Technology stated that it will further optimize the overall layout of the listed company in the field of medical equipment, and at the same time, it will also enhance the existing business scale and profitability of the listed company
.
In recent years, Chutian's acquisitions have actually been very frequent.
On June 9, 2020, Chutian Technology announced that it plans to acquire 66.
25% of the equity of its shareholding subsidiary, Chutian Asset Management, at a transaction price of 600 million yuan, reaching 97.
37% of Romaco.
A series of motions for shares were passed
.
Prior to this, it also successively acquired shares in Changchun Xinhuatong Pharmaceutical Equipment Co.
, Ltd.
(later renamed Chutian Huatong), Pharmaceutical Design Institute, etc.
, and continuously expanded the scale of assets and product types
.
In addition, Canaan Technology, Tofflon and other companies have also been actively conducting mergers and acquisitions in recent years
.
For example, Canaan Technology announced on December 5, 2019 that it planned to invest 24.
75 million yuan in cash to acquire a 45% stake in Beijing Canaan Remit Technology Co.
, Ltd.
Become a wholly-owned subsidiary of the company
.
In addition, Canaan Technology also announced the acquisition of equity interests in Wenzhou Xiaojiang Machinery Technology Co.
, Ltd.
, Yunnan Feiqi Technology Co.
, Ltd.
, Xiaojiang Machinery and other companies
.
Regarding the reasons for the company's series of acquisitions, Canaan Technology once replied to investors on the interactive platform that the company's foreign investment and mergers and acquisitions are based on the company's long-term planning and strategic goals
.
Tofflon also began to accelerate mergers and acquisitions many years ago.
It has successively acquired equity interests in companies such as Shanghai Ruipai Machinery, Shanghai Model Medical, and Shanghai Jianzhong Medical
.
This year, Tofflon also disclosed its deployment in extensional mergers and acquisitions in the first institutional research activity disclosed this year.
It stated that the main purpose of actively carrying out extensional mergers and acquisitions is to complement and improve the company's product line.
Whether the target is overseas or domestic, it will be considered
.
In the field of medical equipment and consumables, it is mainly looking for overseas targets; in the field of bioengineering, the direction of mergers and acquisitions is to improve product lines and build global business
.
At present, the pharmaceutical equipment industry is affected by factors such as policies and pharmaceutical market demand.
While the concentration is increasing, the market competition is also becoming more intense
.
In this context, how to do a good job in the next strategic layout has become a very important topic in the process of enterprise development
.
Judging from the current actions of pharmaceutical machine companies, mergers and acquisitions have obviously become an important part of the current and future corporate strategic layout
.
Disclaimer: Under no circumstances does the information or opinions expressed in this article constitute investment advice to anyone
.
.
According to statistics, judging from the date of the first announcement and excluding transaction failure cases, as of August 23 this year, a total of 1,531 company mergers and acquisitions have occurred in the A-share market, an increase of 23.
66% from 1,238 in the same period last year
.
Mergers and acquisitions have become an important part of the strategic layout of pharmaceutical equipment companies! (Source: Pharmaceutical Network) It is worth noting that, from the perspective of the industry, among the 1,531 company mergers and acquisitions that occurred during the year, the number of mergers and acquisitions in the five industries of pharmaceutical biology, chemical industry, machinery and equipment, electronics and computers ranked the highest, respectively.
There were 174, 150, 135, 105 and 92 cases, accounting for 42.
8% of the total
.
From the above point of view, mergers and acquisitions have obviously become an important way for machinery and equipment companies to enter high-growth and key strategic markets
.
In this regard, the industry expects that the pharmaceutical equipment industry, which is an important member of the machinery and equipment industry, will also accelerate through mergers and acquisitions to expand more market increments for itself
.
In fact, judging from the announcements disclosed by pharmaceutical machine companies and the responses of the companies on the interactive platform, in order to improve future competitiveness, many companies have accelerated their M&A arrangements
.
For example, Truking Technology disclosed the restructuring plan on the evening of July 10, 2022, and the company plans to take the remaining 49% equity of Truking Feiyun into the bag by issuing shares
.
It is understood that as early as 2017, Truking Technology acquired a 51% stake in the newly established Truking Feiyun through capital increase
.
After the completion of this transaction, it means that Truking Feiyun will become a wholly-owned subsidiary of Truking Technology
.
According to the data, Truking Feiyun owns some assets and core technologies, core teams and sales resources of Zhejiang Feiyun, and has a high level of technology and an advantageous position in the field of domestic automatic capsule filling machines
.
Regarding this acquisition, Chutian Technology stated that it will further optimize the overall layout of the listed company in the field of medical equipment, and at the same time, it will also enhance the existing business scale and profitability of the listed company
.
In recent years, Chutian's acquisitions have actually been very frequent.
On June 9, 2020, Chutian Technology announced that it plans to acquire 66.
25% of the equity of its shareholding subsidiary, Chutian Asset Management, at a transaction price of 600 million yuan, reaching 97.
37% of Romaco.
A series of motions for shares were passed
.
Prior to this, it also successively acquired shares in Changchun Xinhuatong Pharmaceutical Equipment Co.
, Ltd.
(later renamed Chutian Huatong), Pharmaceutical Design Institute, etc.
, and continuously expanded the scale of assets and product types
.
In addition, Canaan Technology, Tofflon and other companies have also been actively conducting mergers and acquisitions in recent years
.
For example, Canaan Technology announced on December 5, 2019 that it planned to invest 24.
75 million yuan in cash to acquire a 45% stake in Beijing Canaan Remit Technology Co.
, Ltd.
Become a wholly-owned subsidiary of the company
.
In addition, Canaan Technology also announced the acquisition of equity interests in Wenzhou Xiaojiang Machinery Technology Co.
, Ltd.
, Yunnan Feiqi Technology Co.
, Ltd.
, Xiaojiang Machinery and other companies
.
Regarding the reasons for the company's series of acquisitions, Canaan Technology once replied to investors on the interactive platform that the company's foreign investment and mergers and acquisitions are based on the company's long-term planning and strategic goals
.
Tofflon also began to accelerate mergers and acquisitions many years ago.
It has successively acquired equity interests in companies such as Shanghai Ruipai Machinery, Shanghai Model Medical, and Shanghai Jianzhong Medical
.
This year, Tofflon also disclosed its deployment in extensional mergers and acquisitions in the first institutional research activity disclosed this year.
It stated that the main purpose of actively carrying out extensional mergers and acquisitions is to complement and improve the company's product line.
Whether the target is overseas or domestic, it will be considered
.
In the field of medical equipment and consumables, it is mainly looking for overseas targets; in the field of bioengineering, the direction of mergers and acquisitions is to improve product lines and build global business
.
At present, the pharmaceutical equipment industry is affected by factors such as policies and pharmaceutical market demand.
While the concentration is increasing, the market competition is also becoming more intense
.
In this context, how to do a good job in the next strategic layout has become a very important topic in the process of enterprise development
.
Judging from the current actions of pharmaceutical machine companies, mergers and acquisitions have obviously become an important part of the current and future corporate strategic layout
.
Disclaimer: Under no circumstances does the information or opinions expressed in this article constitute investment advice to anyone
.
